Ectodomain shedding at the cell surface is a major mechanism to regulate the extracellular and circulatory concentration or the activities of signaling proteins at the plasma membrane. Human meprin ! is a 145-KDa disulfidelinked homodimeric multi-domain type-I membrane metallopeptidase that sheds membrane-bound cytokines and growth factors, thereby contributing to inflammatory diseases, angiogenesis, and tumor progression. In addition, amyloid precursor protein (APP) is cleaved at the !-secretase site giving rise to amyloidogenic peptides. We have solved the X-ray crystal structure of a major fragment of the meprin ! ectoprotein, the first of a multi-domain oligomeric transmembrane sheddase, and of its zymogen. The meprin ! dimer displays a compact shape, whose catalytic domain undergoes major rearrangement upon activation, and reveals an exosite and a sugar-rich channel, both of which possibly engage in substrate binding. A plausible structure-derived working mechanism suggests that substrates such as APP are shed close to the plasma membrane surface following an "N-like" chain trace.
INTRODUCTION
Physiological processes in the extracellular milieu and the circulation require finely tuned concentrations of signal molecules such as cytokines, growth factors, receptors, adhesion molecules, and peptidases. Many of these proteins are synthesized as type-I membrane protein variants or precursors consisting of a glycosylated N-terminal ectoprotein, a transmembrane helix, and a C-terminal cytosolic tail. Their localization at the cell surface restricts their field of action to autocrine or juxtacrine processes. However, to act at a distance in paracrine, synaptic, or endocrine events, they have to be released from the plasma membrane into the extracellular space as soluble factors through "protein ectodomain shedding" (1, 2) . This entails limited proteolysis and is a major post-translational regulation mechanism that affects 2-4% of the proteins on the cell surface, occurs at or near the plasma membrane (3) , and apparently follows a common release mechanism (2) . It may also proteolytically inactivate proteins in order to terminate their function on the cell surface (4) . Peptidases engaged in such processing are "sheddases" and the most studied transmembrane sheddases are members of the adamalysin/ADAMs (4, 5) and matrix-metalloproteinase (MMP; (6) ) families within the metzincin clan of metallopeptidases (MPs; (7) (8) (9) ). These include ADAM-8, -9,-10,-12, -15, -17, -19, -28, and -33 (1, 4) ; and membrane-type 1 (MT1)-MMP, MT3-MMP, and MT5-MMP (2, 6, 10) . Other confirmed transmembrane sheddases are the aspartic proteinases BACE-1 and -2 (see (11) and references therein), and the malarian parasite serine proteinases, PfSUB2, PfROM1 and PfROM4 (12) . Distinct sheddases may participate in intercalating processes, with disparate physiological consequences: ADAM-9, -10 ("-secretases), and -17 contribute to the non-amyloidogenic pathway of human amyloid precursor protein (APP) processing, while BACE-1 (!-secretase) participates in the amyloidogenic pathway. While the former generates innocuous peptides, the latter gives rise to the toxic !-amyloid peptides believed to be responsible for Alzheimer's disease (11) . In several instances, shedding at the membrane surface is followed by a "regulated intramembrane proteolysis" step within the membrane (1) . This is the case for the processing of Notch ligand Delta1 and of APP, both carried out by #-secretase after action of an "/!-secretase (11) , and for signal-peptide peptidase, which removes remnants of the secretory protein translocation from the endoplasmic membrane (13) .
Recently, human meprin ! (M!) was found to specifically process APP in vivo, which may contribute to Alzheimer's disease (14, 15) . It was also reported to activate cell-anchored "-secretase ADAM-10 and to be widely expressed in brain, intestine, kidney and skin (14, (16) (17) (18) . Disruption of M! in mice affects embryonic viability, birth weight, and renal gene expression profiles (19) . The enzyme was further identified as a sheddase or proteolytic regulator at the plasma membrane of interleukin-1! (20), interleukin-18 (21) , tumor growth factor " (22) , pro-collagen III (23) , epithelial sodium channel (24) , E-cadherin (25) , tenascin-C (26) , and vascular endothelial growth factor A (27) . Further substrates include fibroblast growth factor 19 and connective tissue growth factor. Altered expression and activity of the enzyme is associated with pathological conditions such as inflammatory bowel disease (28) , tumor progression (29) , nephritis (30) and fibrosis (23) .
M! is a 679-residue secreted multi-domain type-I membrane MP that belongs to the astacin family within the metzincins (7, 9, 16, 31, 32) . The enzyme is glycosylated and assembles into either disulfide-linked homodimers or heterodimers with the closely-related meprin " subunit (33) . M! homodimers are essentially membrane-bound but may also be shed from the surface by ADAM-10 and -17 (34, 35) . To assess function, working mechanism and activation of M!, we analyzed the structure of the major ectoprotein of mature M! (M!$C) and of its zymogen, pro-meprin ! (pM!$C). With regard to transmembrane sheddases, to date only the structures of the isolated monomeric catalytic domains of ADAM-17 (Protein Data Bank [PDB] access code 1BKC), ADAM-33 (PDB 1R55), MT1-MMP (PDB 1BUV), MT3-MMP (PDB 1RM8), BACE-1 (PDB 1FKN) and BACE-2 (PDB 2EWY) have been described. Accordingly, this is the first structural report of a multi-domain oligomeric transmembrane sheddase. This has allowed us a better understanding of the structural basis for latency and activation of this MP and to derive a plausible working mechanism for shedding of glycosylated type-I membrane substrates such as APP at the extracellular membrane surface.
RESULTS AND DISCUSSION
Multi-domain structure of pro-meprin ! ! -We solved the crystal structures of pM!$C (with two molecules in the asymmetric unit) and M!$C (with one molecule; see Supp. Information and Supp. Table S1 ). The pM!$C monomer has overall dimensions of 80!60!70Å (Fig. 1a-c) and a four-domain architecture (Supp. Fig. S2a, b) spanning an N-terminal propeptide (PD; T 23 (37) and ADAM family members (38) .
Zymogenic determinants in pro-meprin ! ! -At V 29 of PD, the chain sharply kinks downwards and runs vertically until G 32 (Fig. 1c) (40) .
The catalytic domain in pro-meprin ! ! -The 198-residue CD is a compact ellipsoid reminiscent of a pac-man (Supp. Fig. S1a, b) . A deep and narrow active-site cleft, which harbors the catalytic zinc ion at mid-width (Supp. Fig.   1c ), separates an upper N-terminal and a lower C-terminal sub-domain (NTS and CTS, respectively) of similar size when viewed in standard orientation (Supp. Fig. S1a ; (41)). CD is cross-linked by two disulfide bonds within the NTS: includes L!10!11-partially undefined in one of the two molecules in the asymmetric unit-and L!11!12, the "dimerization loop" (see below). In addition, the pairs C 265 -C 273 and C 340 -C 427 are at adequate distance and geometry for disulfide bonding but, contrary to the SS-bonds in CD, the respective S# atoms are 2.9Å apart. We attribute this to a radiation-damage artifact due to the long exposure time required to collect a complete dataset in space group P1. In addition, the %3-!10-!11 insertion contributes to an octahedral cation-binding site tentatively interpreted as a sodium site. The ion is coordinated by the side chains of E 268 , D 298 , S 300 , D 418 , and the main-chain oxygen atoms of S 266 and F 310 (Supp. Fig. S1d ). Overall, the topology and architecture of this domain is reminiscent of receptor-type tyrosine-protein phosphatase µ (PDB 2V5Y), which belongs to the MAM protein family of adhesive proteins initially identified by bioinformatic searches in meprin " and !, A5 protein, and receptor protein tyrosine phosphatase µ (46). In particular, the MAM domain of tyrosine phosphatase µ was shown to play a major role in homodimerization of the phosphatase ectoprotein and in cell adhesion (47) .
Downstream of MAM, the 170-residue TRAF domain interacts with the former burying an interface of ~650Å 2 ( Fig. 1a, right) . TRAF also interacts with CD through a surface spanning ~950Å 2 in one protomer and ~1170Å 2 in the other as the polypeptide chain could be traced for four residues more in the latter. TRAF features the second type of all-! structure found in pM! (Supp. (Fig. 1a, left) . Overall, M! TRAF is structurally similar to tumor-necrosis factor receptorassociated factors 2, 3, and 6 (e.g. PDB 1LB5). These gave rise to the TRAF family, which comprises major mediators of cell activation engaged in homo-and hetero-dimerization (48). Accordingly, it is assumed that the glycosylations, which were able to be modeled to up to ten hexose moieties at a single site (N 547 ) and a maximum of 26 hexoses per protein monomer (see Supp. point to the bulk solvent and are isolated in the monomer structure, those of the remaining five sites are all oriented toward the inter-domain space between MAM and TRAF, although they do not contact each other (Fig. 1a, right) .
Glycosylation sites and "sugar channel" -
Given this accumulation, we termed the lumen between MAM and TRAF "sugar channel".
Dimerization of pro-meprin ! ! -Two pM!$C monomers associate to form a compact ellipsoid with dimensions of 115!65!90Å burying an interface of ~1,220Å 2 (4.5% of the total monomer surface; Fig. 1d, e) .
Superposition of the whole monomers (rmsd of 0.84Å for 548 common C" atoms) reveals that while PDs, NTSs, and
TRAFs perfectly fit together, slight deviations are observed for CTSs and MAMs, which lead to displacements of up to 2.8Å (measured at S 182 C") and 2.6Å (at A 410 C"), respectively. and dissolved crystals, thus suggesting a function as a double safeguard rather than a feature indispensable for dimerization. In the particle, the glycans attached at N 254 of each monomer interact with each other and contribute thus to a small hydrophilic cluster on the surface (see below). Moreover, the two CDs (with their attached PDs), as well as the sugar channels, are accessible at opposite ends of the particle, which is consistent with a competent conformation for substrate binding (Fig. 1d, right) , and both C-termini of the dimer are located on the same face of the particle (Fig.   1d ,e). Given that the complete ectoprotein only comprises a further ~60 residues, which mainly contribute to a compact EGF domain (C 608 -C 643 ) before the transmembrane anchor (I 653 -V 673 ), this face is likely to be membrane-proximal and this allowed us to orient the particle with respect to the extracellular plasma membrane surface (Fig. 1d, left) . Further evidence for the consistency of this orientation is based on the proximity of the CDs and their active-site clefts to the membrane surface, which is required if membrane-anchored substrates are to be cleaved close to the membrane. rearrangement observed is compatible with the gross particle structure, indicating that the zymogen is already in a preformed conformation adequate for catalysis, which requires only a rigid-body rearrangement of a sub-domain spanning 1/7 of the full-length protein for full competence.
Maturation also constricts the active-site cleft and this affects the side chain of Y 211 , which is engaged in zinc and substrate binding, and catalysis in mature astacin CDs (i.e. the "tyrosine-switch" residue; (52)) and some other metzincins such as serralysins and pappalysins (8) . In the zymogen, it is pulled away from its competent position by the intercalation of PD helix "1, in particular the side chains of I 37 -F 38 (Fig. 1b) A working mechanism for shedding at the plasma membrane -The structures of both pM!$C and M!$C reveal a dimer with a membrane-proximal face (see above). We constructed a homology model for the remaining ~60
residues of the ectoprotein-mainly encompassing an EGF-like domain-, the 20-residue transmembrane anchor, and the 27-residue cytosolic tail of each monomer (see Supp. Information), which enabled us to propose a molecular mechanism for M!-mediated shedding at the plasma membrane (Fig. 2) . This is visualized utilizing a tentative model for APP region F 624 -L 723 , which includes the final segment of the ectoprotein and the transmembrane helix (55) (Fig. 2 ). An intra-molecular mechanism involving all three domains of one monomer is unlikely as the substrate would have to undergo a long excursion after passing through the sugar channel and the back surface of the cognate CD to reach its active-site cleft with the correct N-to-C polarization (Fig. 1e) . The first residue after the !-secretase cleavage site, D 672 , would be located in the S 1 ' pocket of M!, thus matching its substrate specificity. Further downstream sub-sites of the substrate would run across the cleft and the prime-site exosite on the TRAF surface (see first chapter) of M! monomer two and then turn down to reach the APP transmembrane segment at G 700 . Generally, the substrate would follow an "N-like" trajectory ( Fig. 2 top right) and involve domains from both monomers within the M!-dimer. In addition, this mechanism would be sugar-assisted. The majority of potential shedding substrates (87% of single-pass transmembrane proteins; (56)) are glycosylated, and this holds true also for APP and other M! substrates. In particular, APP is glycosylated at T 633 , T 651 , T 652 , T 659 , T 663 , S 667 , and Y 681 with regard to the segment under inspection here (57). Of these sites, the proposed model predicts that the latter three could be at or close to sub-sites P 5 , P 7 , and P 10 ', i.e. they would not interact with the enzyme but rather solvent exposed. By contrast, the glycans attached to T 651 , T 652 , and T 659 could potentially interact with the site created by the symmetric N 254 glycosylations of M!, and the one at T 633 with that of M! N 436 (Fig. 2) . Overall, this mechanism would be compatible with other type-I transmembrane substrates that are
shed at sites at least 20-25 residues above the membrane. The different N-glycans found on the surface of the M! particle along the proposed substrate path (see Fig. 2 ) could provide alternative anchor points for the particular sugar moieties of each substrate. Green arrows run along the sugar channels and a pink arrow highlights the cleft of one CD with the adequate orientation of a substrate. The segment containing the inter-molecular disulfide bond between C 305 residues is disordered in the zymogen and its approximate position is highlighted by orange ellipses. 
MATERIALS AND METHODS

A detailed description of procedures is provided under
SUPPORTING INFORMATION 1. EXPERIMENTAL PROCEDURES
Protein production -The pro-meprin ! ectomoiety lacking the N-terminal signal peptide and the C-terminal 87 residues (numbering according to the pre-pro-sequence, UniProt Q16820), hereafter referred to as pM!"C, was produced by recombinant baculovirus-induced overexpression in Trichoplusia ni insect cells and activated by trypsin to yield mature meprin ! (M!"C) as reported (1) . In the expression construct T 23 -P 24 were replaced with P 23 -W 24 .
Crystallization and structure solution -Crystallization assays were performed by the sitting-drop vapor Table S1 ).
The structure of pM!"C was solved by a combination of single-wavelength anomalous diffraction and Patterson search. The latter was performed with program PHASER (5) with the structure of crayfish pro-astacin (PDB 3LQ0; (6)), adequately trimmed and modified for its side chains with program CHAINSAW (7), as searching model for the catalytic domain and part of the pro-segment; this gave two unambiguous solutions with space group P1. Diffraction data to 2Å resolution of a crystal collected at the zinc K-edge peak wavelength, as inferred from a previous XANES fluorescence scan, enabled program SHELXD (8) and a (tentative) cadmium replacing the catalytic zinc, which was assigned based on electron-density maps, approximate distances to the protein ligands, and its presence in the crystallization conditions. The intermediate MAM domain is less well defined by electron density than the flanking ones, as revealed by a larger average thermaldisplacement parameter (123Å 2 vs. 109Å 2 and 102Å 2 ). Despite the lower resolution of the diffraction data, the same asparagine residues as in the zymogen plus position 592 showed evident N-linked glycosylations, which total 12 Nacetylglucosamine, 9 #-D-mannose, 3 #-L-fucose, and 2 !-D-mannose moieties. Therefore, we assume that position 592 is likewise glycosylated in the zymogen but that these sugars are flexible. All four cysteine pairs at adequate distance for disulfide bonding were built as disulfide bridges. Segment 300-310, which contains the C 305 -mediated intermolecular disulfide bond, was traced based on weak electron density and should be treated with caution. Extra electron density in the active-site cleft was conservatively interpreted as a glycerol molecule.
Miscellaneous -Figures were prepared with program CHIMERA (11) . Interaction surfaces (taken as half of the surface area buried at a complex interface) were calculated with CNS (12) . Structure similarities were investigated with DALI (13) . Model validation was performed with MOLPROBITY (14) and the WHATCHECK routine of WHATIF (15) . To obtain a working model for the complete active dimer, a homology model for the EGF-like domain of M! (residues 606-647) was constructed with SWISS-MODEL (16) based on a receptor-binding region of Notch ligand (PDB entry 2VJ3; sequence identity 36%; E-value 7.6E-6). This model was connected with constructed models for the transmembrane helix (residues 653-673) and the cytosolic region (674-701), and with the experimental structure
